Take-Two (TTWO) Form 144: Recent Insider Sales Total $5.37M
Rhea-AI Filing Summary
Take-Two Interactive (TTWO) Form 144 notice reports proposed resale of 903 common shares on 09/03/2025 through Fidelity Brokerage on NASDAQ with an aggregate market value of $217,623. The shares were acquired on 09/01/2025 by restricted stock vesting and were paid as compensation. The filing lists total shares outstanding of 184,470,212. Related recent sales by the same person, Daniel Emerson, include 22,479 shares on 08/21/2025 for $5,113,298.13 and 1,083 shares on 09/02/2025 for $256,485.15. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Timely compliance with Rule 144 disclosure requirements for insider sales
- Full disclosure of acquisition method (restricted stock vesting) and that securities were compensation
Negative
- Recent substantial insider sales by the same individual: 22,479 shares on 08/21/2025 for $5,113,298.13 and 1,083 shares on 09/02/2025 for $256,485.15
Insights
TL;DR: Routine Rule 144 sale of recently vested restricted shares; prior larger sales by same individual noted.
The Form 144 documents a planned sale of 903 shares acquired via restricted stock vesting and designated as compensation, to be executed on 09/03/2025 through Fidelity on NASDAQ. The filing discloses recent dispositions by the same individual totaling 23,562 shares in the past two weeks, producing gross proceeds above $5.3 million. For investors, this filing is a compliance disclosure of insider liquidity activity rather than an operational update. The disclosed amounts are small relative to the issuer's reported 184,470,212 shares outstanding, reducing the likelihood of market-impacting dilution from this specific planned sale.
TL;DR: Transparent insider reporting; multiple recent sales warrant attention to insider trading patterns.
The notice shows adherence to Rule 144 disclosure requirements for the resale of vested restricted stock. The seller affirms no undisclosed material adverse information. While the single planned sale is modest, the two earlier sales (08/21/2025 and 09/02/2025) produce sizable proceeds, which may reflect routine diversification or personal liquidity needs rather than a change in company fundamentals. From a governance perspective, timely public reporting supports market transparency.